期刊文献+

利培酮血药浓度的研究进展 被引量:5

下载PDF
导出
摘要 利培酮,商品名"维思通"(risperidal),为苯丙异恶唑(benzisoxazole)类衍化物,自上市以来在临床上获得了较为广泛的应用.随着应用的深入近年来国内外对其血药浓度方面的研究也取得了一些新的进展.与国外相比,国内这方面的研究较为缺乏.现将此领域的进展状况综述如下.
作者 杨春荣
出处 《上海精神医学》 2005年第4期233-235,共3页 Shanghai Archives of Psychiatry
  • 相关文献

参考文献12

  • 1Yasui - Furukori N, Mihara K, Takahata T, et al. Effects of various factors on steady - state plasma concentrations of risperidone and 9 -hydroxyrisperidone: lack of impact of MDR - 1 genotypes. Br J Clin Pharmacol ,2004, 57:569-575.
  • 2Aravagiri M, Marder SR, Nuechterlein KH, et al. Intra - and interindividual variations in steady - state plasma concentrations of risperidone and 9 - hydroxyrisperidone in schizophrenic patients treated chronically with various doses of risperidone. Ther Drug Monit, 2003,25: 657 -664.
  • 3Yasui - Furukori N, Mihara K, Kondo T, et al. Effects of CYP2D6 genotypes on plasma concentrations of risperidone and enantiomers of 9-hydroxyrisperidone in Japanese patients with schizophrenia. J Clin Pharmacol ,2003, 43: 122 - 127.
  • 4Roh HK, Kim CE, Chung WG, et al. Risperidone metabolism in relation to CYP2D6 * 10 allele in Korean schizophrenic patients. Eur J Clin Pharmacol ,2001,57: 671 -675.
  • 5Yasui - Furukori N, Hidestrand M, Spina E, et al. Different enantioselective 9 - hydroxylation of risperidone by the two human CYP2D6 and CYP3A4 enzymes. Drug Metab Dispos ,2001,29: 1263 -126g.
  • 6Eerdekens M, Van Hove I, Remmerie B, et al. Pharmacokinetics and tolerability of long - acting risperidone in schizophrenia. Schizophr Res, 2004 ,70:91 -100.
  • 7Gagliano A, Germano E, Pustorino G, et al. Risperidone treatment of children with autistic disorder: effectiveness, tolerability, and pharmacokinetic implications. J Child Adolesc Psychopharmacol , 2004,14: 39-47.
  • 8Nishikage H, Nakanishi T, Takamitsu Y, et al. Sequential changes in the plasma concentration of risperidone following intentional overdose. Clin Neuropharmacol ,2002 ,25: 307 - 309.
  • 9LLerena A, Berecz R, Dorado P, et al. Determination of risperidone and 9 - hydroxyrisperidone in human plasma by liquid chromatography: application to the evaluation of CYP2D6 drug interactions. J Chromatogr B Analyt Technol Biomed Life Sci ,2003 ,783:213 -219.
  • 10Bork JA, Rogers T, Wedlund PJ, et al. A pilot study on risperidone metabolism: the role of cytochromes P450 2D6 and 3A. J Clin Psychiatry ,2000,61: 600 - 601.

同被引文献47

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部